|
2024 Conference Publication Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare projectAu, T., Bailey, D., Beattie, E., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Dissanayaka, N., Keramat, S.A., Lehn, A., Liddle, J., Marsh, R., Mitchell, L., Naismith, S., Nestor, S., O’Sullivan, J., Pachana, N., Pourzinal, D., Robertson, S., Shrubsole, K., Sivakumaran, K., Spooner, D., Tinson, H., Verreynne, M.L., Worthy, P. and Yang, J. (2024). Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
|
2024 Conference Publication Neuropsychological predictors of cognitive decline in Parkinson's disease: A systematic review (PDCogniCare)Pourzinal, D., Sivakumaran, K., Yang, J., Bailey, D.X., Mitchell, L.K., Brooks, D. and Dissanayaka, N. (2024). Neuropsychological predictors of cognitive decline in Parkinson's disease: A systematic review (PDCogniCare). Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
|
2024 Conference Publication Verbal fluency correlates with medial temporal lobe volumes in Parkinson’s disease with memory impairmentYang, J., Pourzinal, D. and Dissanayaka, N. (2024). Verbal fluency correlates with medial temporal lobe volumes in Parkinson’s disease with memory impairment. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024. |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022. |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022. |
|
2022 Conference Publication Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s diseasePourzinal, D., Yang, J., Byrne, G.J., O’Sullivan, J.D., McMahon, K. and Dissanayaka, N. (2022). Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s disease. UQ Faculty of Medicine HDR Student Symposium, Brisbane, QLD Australia, 7 October 2022. |
|
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |
|
2021 Conference Publication Systematic review of Magnetic Resonance Imaging studies exploring hippocampal correlates of episodic memory in Parkinson’s diseasePourzinal, D., Yang, J., Bakker, A., McMahon, K. L., Byrne, G. J., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Systematic review of Magnetic Resonance Imaging studies exploring hippocampal correlates of episodic memory in Parkinson’s disease. 6th Pacific Rim Conference 2021, Melbourne, VIC, Australia, 30 Jun – 3 Jul 2021. |
|
2021 Conference Publication Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J.H., Byrne, G.J., O’Sullivan, J.D., McMahon, K., Copland, D.A. and Dissanayaka, N. (2021). Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s disease. Australia Dementia Forum 2021, Online, 31 May – 1 June 2021. |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson's diseaseYang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol. UQ Faculty of Medicine Higher Degree by Research Student Symposium, Brisbane, QLD Australia, 23-27 November 2020. |
|
2020 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J. H., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. K., McMahon, K. L., Copland, D. A. and Dissanayaka, N. N. W. (2020). Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease. Australian Society for Medical Research Queensland Postgraduate Student Conference, Online, 11 November 2020. |
|
2020 Conference Publication Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson's diseaseYang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson's disease. Macquarie University BioNetwork 3rd Annual Research Symposium on Dementia, Online, 14-15 September 2020. |
|
2020 Conference Publication Investigating resting state functional connectivity in sub-phenotypes of Mild Cognitive Impairment in Parkinson’s diseasePourzinal, D., Yang, J.H.J., Byrne, G.J., O'Sullivan, J., Mitchell, L., McMahon, K.L., Copland, D.A. and Dissanayaka, N.N. (2020). Investigating resting state functional connectivity in sub-phenotypes of Mild Cognitive Impairment in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020. |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson’s diseaseYang, Ji Hyun, Forbes, Elana, Pourzinal, Dana, McMahon, Katie, Copland, David, Byrne, Gerard, O'Sullivan, John, Mitchell, Leander and Dissanayaka, Nadeeka (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease. Australian Dementia Forum, Adelaide, SA, Australia, 31 May-2 June 2020. Canberra City, ACT, Australia: NHMRC National Institute for Dementia Research (NNIDR). |
|
2020 Conference Publication Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s diseasePourzinal, D., Yang, J.H.J., Byrne, G.J., O'Sullivan, J., Mitchell, L., McMahon, K.L., Copland, D.A. and Dissanayaka, N.N. (2020). Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020. |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson’s diseaseYang, J.H., Forbes, E., Pourzinal, D., McMahon, K., Copland, D.A., Byrne, G.J., O'Sullivan, J., Mitchell, L. and Dissanayaka, N.N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease. MDS Virtual Congress 2020, Online, 12-16 September 2020. |
|
2020 Conference Publication Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G., McMahon, K.L., O'Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N.N.W. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept protocol. Macquarie University BioNetwork 3rd Annual Research Symposium on Dementia, Online, 14-15 September 2020. |
|
2019 Conference Publication Identifying subtypes of Mild Cognitive Impairment in Parkinson’s Disease Using Cluster AnalysisPourzinal, D., Yang, J., Byrne, G. J., O'Sullivan, J D., Mitchell, L., McMahon, K., Copland, D. A. and Dissanayaka, N. N. (2019). Identifying subtypes of Mild Cognitive Impairment in Parkinson’s Disease Using Cluster Analysis. International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, 22-26 September 2019. Hoboken, NJ United States: John Wiley & Sons. |
